US Stock MarketDetailed Quotes

HALO Halozyme Therapeutics

Watchlist
  • 47.540
  • +0.380+0.81%
Close Dec 24 13:00 ET
  • 48.000
  • +0.460+0.97%
Pre 04:45 ET
6.05BMarket Cap15.74P/E (TTM)

Halozyme Therapeutics Key Stats

Halozyme Therapeutics Q3 2024 Earnings Date

Currency:USDOct 31, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
252.17M
290.08M
+37.92M
Beat Est.
+16.73%
+34.28%
+15.04%
EPS
0.83
1.05
+0.22
Beat Est.
+35.59%
+72.13%
+26.95%
Buy

Dec 25, 2024

Halozyme Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 263.208M--
--2024/Q4-- / 286.072M--
Oct 31, 20242024/Q3290.084M / 252.167M--
Aug 6, 20242024/Q2231.353M / 204.941M--
May 7, 20242024/Q1195.879M / 199.649M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 263.208M--
--2024/Q4-- / 286.072M--
Oct 31, 20242024/Q3290.084M / 252.167M--
Aug 6, 20242024/Q2231.353M / 204.941M--
May 7, 20242024/Q1195.879M / 199.649M--

Unlock Free Earnings Estimates

Halozyme Therapeutics Earnings Reports

Read more

Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 25, 2024

Buy

  • Buy

    50.00%
  • Hold

    50.00%
  • Sell

    0.00%

Price Target

No Data